NRXS Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
1.9M
+20.0%
1.6M
+66.1%
968.1K
+19.3%
811.4K
-9.2%
894.1K
Cost of Revenue
272.6K
+24.8%
218.4K
+54.2%
141.7K
+4.5%
135.5K
-7.6%
146.6K
Gross Profit
1.7M
+19.2%
1.4M
+68.1%
826.5K
+22.3%
675.9K
-9.6%
747.4K
Operating Expenses
3.8M
+20.8%
3.1M
+23.1%
2.5M
-8.4%
2.8M
+12.6%
2.5M
R&D
274.3K
+175.5%
99.6K
-31.9%
146.2K
+11.7%
130.8K
+13.6%
115.2K
SG&A
3.5M
+15.7%
3.0M
+26.4%
2.4M
-9.4%
2.6M
+12.6%
2.4M
Operating Income
-2124712
-22.1%
-1740679
-1.4%
-1716868
+18.2%
-2100085
-22.3%
-1717858
EBITDA
-2108061
-22.3%
-1724362
-1.9%
-1692813
+18.8%
-2083880
-22.2%
-1704973
Net Income
-2085746
-18.4%
-1761432
-3.1%
-1708657
+19.5%
-2122796
-25.6%
-1690418
EPS (Basic)
$-0.19
-5.6%
$-0.18
+0.0%
$-0.18
+25.0%
$-0.24
-9.1%
$-0.22
EPS (Diluted)
$-0.19
-5.6%
$-0.18
+0.0%
$-0.18
+25.0%
$-0.24
-9.1%
$-0.22
Shares (Diluted)
12.1M
+10.7%
10.9M
+4.6%
10.5M
+6.0%
9.9M
+15.9%
8.5M
Neuraxis (NRXS) โ€” Financials